Loading...
Cactus Inc (WHD) is not a strong buy right now for a beginner investor with a long-term strategy. While there are positive catalysts such as the company's international expansion and acquisition of Baker Hughes' Surface Pressure Control business, the technical analysis, options data, and financial performance suggest a cautious approach. The stock's recent financials show declining revenue, net income, and gross margin, and technical indicators do not support a strong entry point at the current price. Analysts are optimistic about long-term growth, but the current pre-market price does not present an immediate buying opportunity.
The MACD histogram is negative and expanding (-0.689), indicating bearish momentum. RSI is at 21.833, in the neutral zone, and moving averages are converging, showing no clear trend. Key support levels are at S2: 51.036, close to the current price of 51.63, suggesting limited downside protection. The stock has a 50% chance of declining in the short term (-3.33% in the next day, -4.26% in the next week).

Analysts highlight international expansion and synergies from the Baker Hughes acquisition.
Piper Sandler initiated coverage with an Overweight rating and a $73 price target, citing transformative growth potential.
Citi upgraded the stock to Buy, citing an improving Middle East outlook and potential industry recovery.
Declining financial performance in Q4 2025, with revenue down 17.68% YoY and net income down 14.67% YoY.
Gross margin dropped by 19.62% YoY, indicating operational challenges.
Technical indicators suggest bearish momentum and no clear entry point.
Hedge funds and insiders are neutral, showing no significant trading trends.
In Q4 2025, revenue dropped to $224.005M (-17.68% YoY), net income dropped to $39.838M (-14.67% YoY), and gross margin fell to 30.39% (-19.62% YoY). EPS dropped to 0 (-100% YoY), reflecting significant financial challenges.
Analysts are optimistic about the long-term growth of Cactus Inc. Piper Sandler initiated coverage with an Overweight rating and a $73 price target, citing transformative growth through international expansion. Citi upgraded the stock to Buy with a $55 price target, citing synergies from the Baker Hughes acquisition and an improving Middle East outlook. Barclays raised its price target to $56, maintaining an Overweight rating.